What should be assessed in a male patient presenting with urinary symptoms?

Assessment of Male Urinary Symptoms

Perform a complete medical history, validated symptom questionnaire, physical examination with digital rectal examination, urinalysis, and post-void residual measurement as your initial core assessment. 1

Initial Mandatory Assessments

Medical History

• Document specific LUTS categories: storage symptoms (frequency, nocturia, urgency, urge incontinence) versus voiding symptoms (hesitancy, weak stream, straining, incomplete emptying, terminal dribbling) 1, 2
• Assess symptom severity and bother using validated questionnaires like the International Prostate Symptom Score (IPSS) with quality of life assessment 1
• Review medications that may worsen urinary symptoms (anticholinergics, decongestants, diuretics) 3
• Screen for comorbidities: diabetes, neurological conditions, prior pelvic surgery, urolithiasis history, hematuria 1, 4

Physical Examination

• Perform digital rectal examination to assess prostate size, consistency, nodularity, and tenderness 1
• Examine genitalia for meatal stenosis, phimosis, or other abnormalities 3
• Assess for neurological deficits if neurogenic bladder is suspected 5

Urinalysis

• Dipstick or microscopy is mandatory to detect blood, glucose, protein, leucocytes, and nitrites 1
• This screens for urinary tract infection, diabetes, and bladder pathology 3

Bladder Diary

• Use a frequency-volume chart for at least 3 days in patients with prominent storage symptoms or nocturia 1
• This objectively quantifies voiding patterns, fluid intake, and functional bladder capacity 4, 3

Objective Measurements

Post-Void Residual (PVR)

• Measure PVR in all patients to identify urinary retention and assess bladder emptying efficiency 1, 4
• Elevated PVR (>200-300 mL) suggests bladder outlet obstruction or detrusor underactivity 2

Uroflowmetry

• Perform uroflowmetry before any medical or invasive treatment (strong recommendation) 1
• Initial assessment uroflowmetry has weaker evidence but helps establish baseline flow patterns 1, 4
• Maximum flow rate <10-15 mL/s with adequate voided volume suggests obstruction 2

Selective Assessments Based on Clinical Context

Prostate-Specific Antigen (PSA)

• Measure PSA only if prostate cancer diagnosis would change management or if it assists in treatment decision-making for patients at risk of symptom progression 1
• Counsel patients about PSA testing implications before ordering, including false positives and potential for overdiagnosis 1
• PSA can predict risk of acute urinary retention and need for surgery in BPH management 1

Renal Function

• Assess renal function if: renal impairment is suspected from history/examination, hydronephrosis is present, or surgical treatment is being considered 1

Imaging Studies

Upper Urinary Tract Ultrasound:

• Perform in men with: large PVR, hematuria, or history of urolithiasis 1, 4

Prostate Imaging (Transrectal or Transabdominal Ultrasound):

• Weak recommendation for medical treatment if it assists in drug selection 1
• Strong recommendation before surgical treatment to determine prostate volume, which guides procedural choice 1
• Prostate volume >40 mL predicts progression risk and influences treatment selection (5-ARIs more effective in larger prostates) 1

Urethrocystoscopy

• Perform selectively in patients with: history of hematuria, urethral strictures, bladder cancer, or before minimally invasive/surgical therapies if findings may change treatment 1, 4
• Presence of middle lobe may contraindicate certain procedures 1

Urodynamic Studies

• Reserve for specific indications: before surgery in complicated cases, when pathophysiology is uncertain, or when conservative management has failed 1, 4
• The UPSTREAM trial demonstrated urodynamics should be used selectively rather than routinely in uncomplicated LUTS 1
• Pressure-flow studies can identify bladder outlet obstruction (61% associated with detrusor overactivity) and detrusor underactivity (11-40% of men with LUTS) 1

Critical Pitfalls to Avoid

• Do not assume all male LUTS are due to BPH—consider overactive bladder, neurogenic bladder, urethral stricture, bladder cancer, and medication effects 2, 6
• Do not order PSA reflexively—it requires informed consent and should only be obtained when actionable 1
• Do not skip PVR measurement—chronic retention can be asymptomatic and lead to renal impairment 1
• Alert ophthalmology if cataract surgery is planned—alpha-blockers increase risk of intraoperative floppy iris syndrome 1